Pimozide and pancreatic cancer in diabetic chorea: a case report

Currò, Carmelo Tiberio; Nicocia, Giacomo; Ziccone, Vanessa; Ciacciarelli, Antonio; Russo, Giuseppina; Toscano, Antonio; Terranova, Carmen; Girlanda, Paolo

doi:10.1080/00207454.2021.1879063

Search citation statements

Order By: Relevance

Paper Sections

Select...

Blood Glucose-related Chorea1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DS Treatment primarily involves blood glucose control, and most patients experience gradual improvement over several days or weeks. If chorea symptoms do not resolve in the absence of hyperglycemia, haloperidol, pimozide, and other dopamine receptor antagonists can be administered (63,78,81,84). However, as dopamine receptor antagonists can cause delayed dyskinesia, treatment dosage should be tailored to meet individual requirements.…”

Section: Blood Glucose-related Choreamentioning

confidence: 99%

Chorea: An unusual manifestation of endocrine diseases

Zheng

Wu²

2023

Front. Endocrinol.

View full text Add to dashboard Cite

Chorea is a movement disorder involving involuntary movements of muscles of the face, neck, and limbs, usually caused by basal ganglia lesions. As an important part of the presentation of many neurological diseases, chorea is also an unusual manifestation of endocrine diseases and can be challenging to diagnose. Although the most common etiology of chorea is genetic, it is vital to identify acquired or symptomatic chorea, as these are potentially treatable conditions. This review summarizes the latest developments in various endocrine disease-related chorea, which will help clinicians to correctly identify and accurately treat it.

show abstract

Section: Blood Glucose-related Choreamentioning

confidence: 99%